Evidence map›Paper›PMID 42876763›Full record

ArticleFrontiers in immunology2026

A defined isothiocyanate mixture suppresses platelet signaling and metabolism to limit thrombosis

Jan Yağız Buchholz, Maria Shoykhet, Anthea C Darius, Tobias Weiser, Erika Lynn Roberts, Mohammad Khosravi, Julie Petry, Seyedeh Zahra Mousavi, Babak Mohammadian, Lina Adams and 7 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jan Yağız Buchholz *Department of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Maria Shoykhet *Department of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Anthea C DariusDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Tobias WeiserDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Erika Lynn RobertsDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Mohammad KhosraviDepartment of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Julie PetryDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Seyedeh Zahra MousaviDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Babak MohammadianDepartment of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Lina AdamsDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Khouloud HachaniDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Carola EberhagenInstitute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Omid AzimzadehSection Radiation Biology, Federal Office for Radiation Protection (BfS), Neuherberg, Germany.
Hans ZischkaInstitute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Gabriele MulthoffCentral Institute for Translational Cancer Research, Technical University of Munich (TranslaTUM), Klinikum rechts der Isar, Munich, Germany.
Ali Bashiri DezfouliDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Barbara WollenbergDepartment of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological platelet activation drives thrombosis and is a major contributor to morbidity and mortality. Current antiplatelet therapies reduce thrombotic risk but target a limited range of signaling pathways, have minimal impact on established platelet aggregates, and are frequently associated with bleeding complications. These drawbacks have prompted interest in alternative antiplatelet strategies. Isothiocyanates (ITCs), phytochemicals from cruciferous plants, have been reported to inhibit platelet function; however, their mechanisms and translational relevance remain incompletely defined. The effects of a defined mixture of allyl-, benzyl-, and phenethyl-isothiocyanate on platelet function were evaluated using

Indexed as

Blood PlateletsIsothiocyanatesPlatelet Aggregation InhibitorsSignal TransductionThrombosisAnimalsDisease Models, AnimalHumansMaleMiceMitochondriaPlatelet ActivationPlatelet AggregationIsothiocyanatesPlatelet Aggregation Inhibitorsantithrombotic therapyisothiocyanates (ITCs)mitochondrial dysfunctionoxidative stressplatelet activationplatelet aggregation

Identifiers

PMID42876763
PMCPMC13661427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.